1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

  • June 2014
  • -
  • Visiongain
  • -
  • 189 pages

Summary

Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.


Report Details
Kinase inhibitors – a new study showing you trends, R&D and predicted revenues
Do you want to find sales potentials of kinase inhibitors? Now get the latest analysis for those cancer treatments. There you explore developments, other trends, results, opportunities and revenue forecasts.

Visiongain’s new report shows you what’s possible for drugs using protein kinase inhibition and related technology. There avoid missing out in data. Instead find progress in that industry and market, discovering expected advances and sales. See now how you can gain.

You assess trends, technologies and products, benefiting your reputation for technological, medical and commercial insight.

Progress of that industry – see what’s possible for those anti-cancer medicines
There you explore the future of those therapies. Read on to investigate that industry and see how high its future sales could go.

Forecasts and other information showing technical, clinical and commercial possibilities
That new study gives you sales predictions to 2024 at overall world market, submarket, company, product and national level. See what the future holds. For those drugs you investigate where demand and money lie.

There hear what’s possible. And avoid struggles to find information. Besides giving revenue predictions, that new analysis shows historical results, growth rates and market shares.

In that work you discover 77 tables, 81 charts and an interview with a company. There help your research, analyses and decisions, also benefiting your influence.

And the following sections explain what our new investigation gives you.

Forecasting of that world market and its segments
What’s the potential of that biomedical industry? What’re the secrets of its progress? Find in our report overall world revenue to 2024 from inhibition of protein kinases.

There also find individual revenue predictions to 2024 – with discussions – for seven submarkets at world level:
- Bcr-Abl inhibitors
- Angiogenesis inhibitors
- EGFR inhibitors
- mTOR inhibitors
- Other kinase agents
- BRAF and MEK products
- Generic drugs (generics) and related medicines.

You assess outlooks for expansion in trade, hearing where potential sales increases exist. That work investigates products, uses and revenues past and future. Find what’s possible.

Our study also explores competition. There you see what’s happening for developers, producers and sellers of kinase inhibiting agents, understanding challenges, trends and outlooks. You also explore revenues by product.

Drug forecasts – existing and expected therapies
Discover sales potentials for leading brands, too, seeing how they can compete and succeed. How will 35 cancer treatments perform to 2024 at world level?

Our work shows you individual revenue predictions for 24 top products, including Gleevec, Sprycel, Tasigna, Tarceva and Iressa. It also gives sales predictions for 11 expected drugs, including Palbociclib, Bemaciclib, Alectinib, Ceritinib and Idelalisib.

Also that work splits its overall world market into geographical forecasts.

Healthcare in national markets – what outlooks for that business?
Advances in pharmaceutical biotechnology and healthcare expand use of anti-cancer drugs, including kinase inhibitors. See prospects for developed and developing regions.

Our analyses show you individual revenue forecasts to 2024 for 11 countries:
- United States (US)
- Japan
- Germany, France, UK, Italy and Spain (EU5), also with overall EU prediction
- Brazil, Russia, India and China (BRIC nations).

There you find countries with highest revenues, demand and potential sales. Explore progress, needs and opportunities, seeing how you can gain.

Also how do events, challenges and advances in technology affect that industry and market? O

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected ...

Targeted Therapies in Asthma - 2017

Targeted Therapies in Asthma - 2017

  • $ 8355
  • Industry report
  • February 2017
  • by Firstword Pharma

Description As new targeted asthma therapies emerge, is time running out for Xolair? Xolair’s unique position in the targeted asthma treatment market is under threat. Teva’s Cinqair and GSK’s Nucala ...

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. In this report, ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.